239 related articles for article (PubMed ID: 29194051)
1. Blood, tissue and imaging biomarkers in calcific aortic valve stenosis: past, present and future.
Shen M; Tastet L; Bergler-Klein J; Pibarot P; Clavel MA
Curr Opin Cardiol; 2018 Mar; 33(2):125-133. PubMed ID: 29194051
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis.
Shah SM; Shah J; Lakey SM; Garg P; Ripley DP
Open Heart; 2023 Mar; 10(1):. PubMed ID: 36963766
[TBL] [Abstract][Full Text] [Related]
3. Calcific aortic stenosis.
Lindman BR; Clavel MA; Mathieu P; Iung B; Lancellotti P; Otto CM; Pibarot P
Nat Rev Dis Primers; 2016 Mar; 2():16006. PubMed ID: 27188578
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis.
Patel N; Kumbhani DJ
Curr Heart Fail Rep; 2018 Oct; 15(5):281-286. PubMed ID: 30062624
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
6. Aortic Stenosis Prognostication in Patients With Type 2 Diabetes: Protocol for Testing and Validation of a Biomarker-Derived Scoring System.
Giritharan S; Cagampang F; Torrens C; Salhiyyah K; Duggan S; Ohri S
JMIR Res Protoc; 2019 Aug; 8(8):e13186. PubMed ID: 31407670
[TBL] [Abstract][Full Text] [Related]
7. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
[TBL] [Abstract][Full Text] [Related]
8. Aortic stenosis - pathogenesis, prediction of progression, and percutaneous intervention.
Natarajan D; Prendergast B
J R Coll Physicians Edinb; 2017 Jun; 47(2):172-175. PubMed ID: 28675194
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.
Yeang C; Wilkinson MJ; Tsimikas S
Curr Opin Cardiol; 2016 Jul; 31(4):440-50. PubMed ID: 27205885
[TBL] [Abstract][Full Text] [Related]
10. Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis.
Mawad W; Abadir S; Fournier A; Bigras JL; Curnier D; Kadem L; Dahdah N
Pediatr Cardiol; 2015 Dec; 36(8):1735-41. PubMed ID: 26123813
[TBL] [Abstract][Full Text] [Related]
11. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
Pasipoularides A
J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
[TBL] [Abstract][Full Text] [Related]
12. Multimodality Imaging Strategies for the Assessment of Aortic Stenosis: Viewpoint of the Heart Valve Clinic International Database (HAVEC) Group.
Dulgheru R; Pibarot P; Sengupta PP; Piérard LA; Rosenhek R; Magne J; Donal E; Bernard A; Fattouch K; Cosyns B; Vannan M; Gillam L; Lancellotti P
Circ Cardiovasc Imaging; 2016 Feb; 9(2):e004352. PubMed ID: 26863917
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
[TBL] [Abstract][Full Text] [Related]
14. Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study.
Abdelbaky A; Corsini E; Figueroa AL; Subramanian S; Fontanez S; Emami H; Hoffmann U; Narula J; Tawakol A
Atherosclerosis; 2015 Feb; 238(2):165-72. PubMed ID: 25525744
[TBL] [Abstract][Full Text] [Related]
15. The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach.
Fabiani I; Conte L; Pugliese NR; Calogero E; Barletta V; Di Stefano R; Santoni T; Scatena C; Bortolotti U; Naccarato AG; Petronio AS; Di Bello V
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1915-1920. PubMed ID: 28664478
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of Calcific Aortic Valve Disease.
Small A; Kiss D; Giri J; Anwaruddin S; Siddiqi H; Guerraty M; Chirinos JA; Ferrari G; Rader DJ
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):623-632. PubMed ID: 28153876
[TBL] [Abstract][Full Text] [Related]
17. Monitoring calcific aortic valve disease: the role of biomarkers.
Latsios G; Tousoulis D; Androulakis E; Papageorgiou N; Synetos A; Tsioufis C; Toutouzas K; Stefanadis C
Curr Med Chem; 2012; 19(16):2548-54. PubMed ID: 22489716
[TBL] [Abstract][Full Text] [Related]
18. Calcific aortic valve disease: is it another face of atherosclerosis?
Sathyamurthy I; Alex S
Indian Heart J; 2015; 67(5):503-6. PubMed ID: 26432749
[TBL] [Abstract][Full Text] [Related]
19. Targeting vasoactive peptides for managing calcific aortic valve disease.
Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
[TBL] [Abstract][Full Text] [Related]
20. Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis.
Généreux P; Stone GW; O'Gara PT; Marquis-Gravel G; Redfors B; Giustino G; Pibarot P; Bax JJ; Bonow RO; Leon MB
J Am Coll Cardiol; 2016 May; 67(19):2263-2288. PubMed ID: 27049682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
